Maravai LifeSciences Holdings, Inc. (MRVI) stock analysis
MRVI · Maravai LifeSciences Holdings, Inc.
Latest recorded price: USD 7.40
Model-estimated fair value: USD 0.00. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Biotechnology
At $7.40, MRVI trades 433,364.9% above the model's base-case value of $0.00. Fiscal 2025 figures: revenue growth -40.5%, free cash flow margin -38.1%, ROIC -59.4%. The model flags 2 risk signals for this company (2 high severity).